In contrast to the GCH1 PP haplotype leading to moderate reduction of BH4 availability and only after stimulation, loss of function mutations in the GCH1 gene causes reduced basal concentrations of BH4 and is associated with DOPA-responsive Dystonia (DRD). Here, GCH1 is linked to dystonia 5.